QCOM:NASDAQQUALCOMM Incorporated Analysis
Data as of 2026-05-23 - not real-time
$238.16
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
QUALCOMM shares are trading at $238.16, well above the DCF-derived fair value of $113 and showing a -25% downside from intrinsic estimates. The stock sits above its 20‑day SMA ($194.90) and 50‑day SMA ($156.56) while the 200‑day SMA ($160.55) still lags, indicating a short‑term price surge on top of a longer‑term neutral trend. Technicals are mixed: RSI is at 71.7 (overbought), MACD remains bullish but with a modest histogram (+0.80), and volume is decreasing, suggesting fading momentum. Volatility is elevated at 87% over the past 30 days and beta exceeds 1.5, reflecting heightened market sensitivity. Fundamentals show a 3.5% revenue decline, solid operating margin (22%), strong cash flow, and a sustainable dividend yield of 1.55% with a 38% payout ratio. Recent material news highlights aggressive AI‑driven data‑center processor plans, new Snapdragon platforms, and analyst upgrades pushing price targets toward $280, underscoring growth expectations despite current overvaluation.
Given the overbought technical profile and a valuation gap, short‑term upside appears limited, but the company’s robust cash generation, strategic AI/automotive initiatives, and dividend stability support a longer‑term buy case once pricing normalizes.
Given the overbought technical profile and a valuation gap, short‑term upside appears limited, but the company’s robust cash generation, strategic AI/automotive initiatives, and dividend stability support a longer‑term buy case once pricing normalizes.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in overbought territory
- Proximity to resistance at $247.90
- Decreasing volume and high volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue contraction of -3.5%
- Analyst upgrades targeting $280
- Continued AI and automotive expansion
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong free cash flow and ROE > 35%
- Strategic AI/data‑center product pipeline
- Sustainable dividend with low payout ratio
Key Metrics & Analysis
Financial Health
Revenue Growth-3.50%
Profit Margin22.31%
P/E Ratio25.6
ROE36.08%
ROA12.69%
Debt/Equity55.98
P/B Ratio9.2
Op. Cash Flow$14.3B
Free Cash Flow$9.6B
Industry P/E39.5
Technical Analysis
TrendNeutral
RSI71.7
Support$144.00
Resistance$247.90
MA 20$194.90
MA 50$156.56
MA 200$160.55
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$113.20
Target Price$177.81
Upside/Downside-25.34%
GradeOvervalued
TypeGrowth
Dividend Yield1.55%
Risk Assessment
Beta1.69
Volatility87.23%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.